Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors

This study has been completed.

Study NCT00355888 Information provided by Mebiopharm Co., Ltd

First Received: July 24, 2006 Last Updated: September 15, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2009
Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)